Matthew Scullion

Matthew Scullion is a seasoned finance professional with extensive experience in portfolio management, corporate development, and asset management. Currently serving as Managing Director at ORIX Corporation USA since 2012, Matthew oversees Non-Core Portfolio Management, Financial Operations, and Corporate Development, specializing in mergers, acquisitions, and divestitures, as well as healthcare capital investment. Previous roles include Board Member at Matawan Pharmaceuticals and Translational Drug Development (TD2) and Vice President and Controller at American Express. Matthew's foundations were built at EY as a Senior Manager and further enhanced through an MBA from Columbia Business School and a BS in Accounting from Penn State University, complemented by holding a CPA designation in New York.